May 21 |
AstraZeneca shares rise as pharma group unveils 2030 revenue target
|
May 21 |
AstraZeneca aims for $80 billion in total revenue by 2030
|
May 21 |
AstraZeneca sets ambition to deliver $80 billion Total Revenue by 2030 and sustained growth post 2030
|
May 21 |
European stocks fall on Fed rate concerns; AstraZeneca lifts revenue target
|
May 20 |
Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute
|
May 20 |
Amgen/AstraZeneca Say Asthma Drug Shows Activity In Another Lung Disease Across Broad Patient Population
|
May 20 |
AstraZeneca, Amgen release mid-stage data on Tezspire for COPD
|
May 20 |
AstraZeneca to build $1.5B ADC manufacturing plant in Singapore
|
May 20 |
AstraZeneca (AZN) to Build $1.5B Cancer Drug Plant in Singapore
|
May 20 |
Trending tickers: Gold, Ryanair, Nvidia and AstraZeneca
|